- Stoke Therapeutics shares gain 78% after test results
- Morgan Stanley boosts sentiment around Seagate shares
Wall Street indices started Tuesday's trading session slightly higher, with investors attempting to resume the rally that drove stocks to record highs after falling in the previous session. At this point, the S&P500 is gaining 0.22%, the Nasdaq is adding 0.4% and the Russell 2000 is adding 0.78%.
Start investing today or test a free demo
Create account Try a demo Download mobile app Download mobile appSource: xStation5
The US2000 index is gaining nearly 0.33% at the start of Tuesday's trading session, holding the psychological barrier of 2,100 points. Maintaining this zone could be key to maintaining the overall uptrend. A drop below, on the other hand, could initiate a downward correction. A possible zone of possible restriction could be the area of the 50% Fibo of the 2021 decline wave and the 50-day exponential moving average (blue curve).Source: xStation
News
Stoke Therapeutics (STOK.US) shares are up 78% today after the company announced that data from a study of the STK-001 treatment for Dravet syndrome showed significant effects in reducing seizures.
Seagate (STX.US) is up 4% after Morgan Stanley raised its recommendation on the company's stock to "outperform," predicting a period of "structurally stronger gross margins."
Krispy Kreme shares jumped 15% after the announcement that the company's doughnuts will be sold in McDonald's (MCD.US) restaurants across the United States.
Analyst action
- Wedbush raises its target price for Microsoft (MSFT.US) shares to $500 from $475, citing the transformative impact of AI, which is expected to change the Cloud division's growth trajectory in the coming years.
- JPMorgan raises its target price for Stoke Therapeutics (STOK.US) shares to $13 from $6 after encouraging results from the first phase of the dravet treatment.
The content of this report has been created by XTB S.A., with its registered office in Warsaw, at Prosta 67, 00-838 Warsaw, Poland, (KRS number 0000217580) and supervised by Polish Supervision Authority ( No. DDM-M-4021-57-1/2005). This material is a marketing communication within the meaning of Art. 24 (3) of Directive 2014/65/EU of the European Parliament and of the Council of 15 May 2014 on markets in financial instruments and amending Directive 2002/92/EC and Directive 2011/61/EU (MiFID II). Marketing communication is not an investment recommendation or information recommending or suggesting an investment strategy within the meaning of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (market abuse regulation) and repealing Directive 2003/6/EC of the European Parliament and of the Council and Commission Directives 2003/124/EC, 2003/125/EC and 2004/72/EC and Commission Delegated Regulation (EU) 2016/958 of 9 March 2016 supplementing Regulation (EU) No 596/2014 of the European Parliament and of the Council with regard to regulatory technical standards for the technical arrangements for objective presentation of investment recommendations or other information recommending or suggesting an investment strategy and for disclosure of particular interests or indications of conflicts of interest or any other advice, including in the area of investment advisory, within the meaning of the Trading in Financial Instruments Act of 29 July 2005 (i.e. Journal of Laws 2019, item 875, as amended). The marketing communication is prepared with the highest diligence, objectivity, presents the facts known to the author on the date of preparation and is devoid of any evaluation elements. The marketing communication is prepared without considering the client’s needs, his individual financial situation and does not present any investment strategy in any way. The marketing communication does not constitute an offer of sale, offering, subscription, invitation to purchase, advertisement or promotion of any financial instruments. XTB S.A. is not liable for any client’s actions or omissions, in particular for the acquisition or disposal of financial instruments, undertaken on the basis of the information contained in this marketing communication. In the event that the marketing communication contains any information about any results regarding the financial instruments indicated therein, these do not constitute any guarantee or forecast regarding the future results.
